Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Health https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ The FDA approves Wegovy, a new anti-obesity drug

The FDA approves Wegovy, a new anti-obesity drug

America has a new weapon in the fight against obesity. On Friday, the FDA approved a new weight loss drug, Wegovy, for people who are either obese or overweight and have at least one medical problem related to weight.

“We need to think about obesity, no different from hypertension, high cholesterol and diabetes,” said Dr. Domenica Rubino, director of the Washington Center for Weight Management and Research.

Rubino said people taking existing obesity medications lose an average of about 7% to 9% of their body weight. “People who need 10%, 15%, 20% weight loss need tools,” she said.

During a 1

6-month study, Wegovy’s patients lost an average of 17% of their body weight. Side effects include diarrhea and nausea, which usually go away as the dose is slowly increased. Patients withdrawn from the drug received more than half of their weight loss.

Trial participant Lisa Robillard lost 63 kilograms. She said she had previously tried fashionable diets or other methods that she thought would help her lose weight.

“I wasn’t hungry between meals, which was just unheard of for me. I was faster and faster and I longed to be gone,” she said of the new drug.

Source link